MCMedicalCodingSoftware
Q82.2

Q82.2: Congenital cutaneous mastocytosis

Billable / specific codeICD-10-CMPOA exempt

Q82.2 is a billable, specific ICD-10-CM code for congenital cutaneous mastocytosis. It is valid for submission on a claim.

Check Q82.2 with the rest of the claim: free scrubber

Excludes1: never code together

These conditions cannot occur together. Billing both on the same encounter is a denial.

  • cutaneous mastocytosis NOS (D47.01)
  • diffuse cutaneous mastocytosis (with onset after newborn period) (D47.01)
  • malignant mastocytosis (C96.2-)
  • systemic mastocytosis (D47.02)
  • urticaria pigmentosa (non-congenital) (with onset after newborn period) (D47.01)

Inclusion terms

Alternative wordings a physician may use in the chart for this same code.

  • Congenital diffuse cutaneous mastocytosis
  • Congenital maculopapular cutaneous mastocytosis
  • Congenital urticaria pigmentosa

Excludes1 inherited from the categories above Q82.2

A category’s note binds every code beneath it.

Written on Q82: Other congenital malformations of skin

  • acrodermatitis enteropathica (E83.2)
  • congenital erythropoietic porphyria (E80.0)
  • pilonidal cyst or sinus (L05.-)
  • Sturge-Weber (-Dimitri) syndrome (Q85.89)

Other codes that can never be billed with Q82.2

Their own Excludes1 notes name this code, so the conflict is not listed above.

  • C96.2Malignant mast cell neoplasm
  • D89.4Mast cell activation syndrome and related disorders
  • D47.01Cutaneous mastocytosis
  • D47.0Mast cell neoplasms of uncertain behavior

Risk adjustment

No CMS-HCC V28 category: this code does not change a RAF score.

Medicare coverage

Q82.2 is named in 13 Medicare coverage policies: 13 listing it as supporting medical necessity. Which one applies depends on your Medicare contractor.

  • A57044Billing and Coding: Removal of Benign Skin Lesions
  • A57837Billing and Coding: MolDX: Next-Generation Sequencing Lab-Developed Tests for Myeloid Malignancies and Suspected Myeloid Malignancies
  • A57873Billing and Coding: MolDX: Next-Generation Sequencing Lab-Developed Tests for Myeloid Malignancies and Suspected Myeloid Malignancies
  • A57878Billing and Coding: MolDX: Next-Generation Sequencing Lab-Developed Tests for Myeloid Malignancies and Suspected Myeloid Malignancies

Alphabetic index entries that lead here

  • Mastocytosis›cutaneous›congenital
  • Mastocytosis›cutaneous›of neonatal onset
  • Mastocytosis›cutaneous›of newborn onset
  • Urticaria›pigmentosa›congenital
  • Urticaria›pigmentosa›of neonatal onset
  • Urticaria›pigmentosa›of newborn onset

Code history

Unchanged in every release from FY2024 to FY2027.

Other codes under Q82

ICD-10-CMFY2027· effective October 1, 2026

Loaded directly from the CMS/NCHS ICD-10-CM public-domain release: see data sources and our editorial policy. If this page disagrees with the CMS tabular list, this page is wrong. Reference information for professional coders; not medical or billing advice.